Octave Strengthens Clinical Expertise in MS and Neurodegenerative Disease – Read the Release

Recent Announcements & Press

Octave Strengthens Clinical Expertise in MS and Neurodegenerative Disease

Octave® Bioscience, Inc. Announces Publication of Real-World Evidence Study in Multiple Sclerosis Journal – ET&C

Octave’s CEO Doug Biehn sits down with Nasdaq’s Leigh Hixon

Octave Note

MSMilan2023: Making a Mark at the World’s Largest MS Research Meeting

ACTRIMS Preview: Advancing the Science for Patients with MS

Barriers in MS Treatment Adherence

Media Library

living well

Bridging MS: Connecting You to Resources

living well

MRI in MS: From Pixels to Progress

living well

Multiple Sclerosis in Childhood